Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Dianthus Therapeutics SVP General Counsel Adam Veness melepas saham senilai USD 2,21 juta

Dianthus Therapeutics SVP General Counsel Adam Veness melepas saham senilai USD 2,21 juta

ReutersReuters2026/08/11 21:09
  • SVP, General Counsel dan Secretary Adam M Veness melepas seluruh kepemilikan saham biasa Dianthus Therapeutics.
  • Ia mengeksekusi 20.000 saham pada USD 17,88 pada 7 Agustus dan 10 Agustus 2026.
  • Ia menjual 20.000 saham pada harga rata-rata tertimbang sekitar USD 110,63 per saham, sehingga kepemilikan saham menjadi nol.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001778623-26-000007), on August 11, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

JPMorgan warns: The EU 'Transition Fund' label is too strict and may hinder financing for emerging markets

JPMorgan's asset management division stated that the planned “transition” fund label in Europe could unnecessarily exclude related assets from an important source of financing.

智通财经2026/09/07 11:06
JPMorgan warns: The EU 'Transition Fund' label is too strict and may hinder financing for emerging markets